Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis
Ημερομηνία
2018Γλώσσα
en
Λέξη-κλειδί
Επιτομή
[No abstract available]
Collections
Related items
Showing items related by title, author, creator and subject.
-
Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?
(2022)The purpose of this review is to examine whether there is a possible (etiological/triggering) relationship between infection with various Coronaviruses, including Severe Acute Respiratory Syndrome-related Coronavirus-2 ... -
Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study ‘TOPICS Greece’
(2021)Background and Objectives: For chronic diseases like multiple sclerosis (MS), real-world evidence on long-term treatment outcomes is essential. The study aimed to provide long-term data on the safety and effectiveness of ... -
Geography of hospital admissions for multiple sclerosis in Greece
(2021)Background: Multiple sclerosis (MS) is the 2nd most common, disability causing neurological disorder in young adults, known for its differences in prevalence according to geographical position. Data on MS epidemiology is ...